Gallacher Capital Management LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1960749
LONE TREE, CO
Position in HRMY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$242,709
-$112,149 QoQ
Shares Held
6,666
-47.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#236
of 328 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gallacher Capital Management LLC holds $2,342,787 across 8 Biotechnology names. HRMY ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
10,486 | $570,543 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
5,264 | $412,013 | |
| 3 | GMAB |
Genmab A/S
|
14,240 | $391,172 | |
| 4 | ARGX |
Argenx SE
|
304 | $282,042 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
6,666 | $242,709 | |
| 6 | BNTX |
BioNTech SE
|
2,448 | $227,786 | |
| 7 | INVA |
Innoviva, Inc.
|
9,067 | $205,911 | |
| 8 | ANVS |
Annovis Bio, Inc.
|
5,705 | $10,611 |
All Filings in HRMY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,709 | 6,666 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $354,858 | 12,669 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $587,119 | 15,690 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $443,467 | 16,091 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $315,399 | 9,981 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $317,561 | 9,568 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||